KRMD · KORU Medical Systems, Inc.
$4.07
+0.06 (+1.37%)
At close · Jul 29
Market Cap
$184.19M
Shares
45.93M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$41.13M
+22.2%
FY2025
Net Income
-$2.64M
+56.5%
FY2025
Gross Margin
62.26%
-1.1pp
FY2025
Operating Margin
-7.23%
+11.9pp
FY2025
Diluted EPS
-$0.06
+53.8%
FY2025
Operating Cash Flow
$462.41K
+244.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $47.5M – $50M | $43.26M | $41.13MG | $33.65M | $28.52M | $27.9M | $23.49M | $24.18M | $23.16M | $17.35M | $12.29M | $12.25M | $8.7M | $7.76M | $6.39M | |
| — | $16.47M | $15.52M | $12.31M | $11.81M | $12.53M | $9.72M | $9.24M | $8.31M | $6.54M | $4.72M | $4.64M | $3.39M | $2.82M | $2.25M | |
| — | $26.79M | $25.6M | $21.33M | $16.71M | $15.37M | $13.77M | $14.94M | $14.85M | $10.81M | $7.57M | $7.6M | — | — | — | |
| — | — | 62.26% | 63.4% | 58.59% | 55.09% | 58.62% | 61.78% | 64.13% | 62.29% | 61.57% | 62.08% | — | — | — | |
| — | $4.59M | $4.39M | $5.26M | $5.74M | $4.96M | $2.47M | $1.3M | $740.48K | $241.12K | $237.49K | $207.28K | $218.15K | $147.58K | $90.33K | |
| — | $24M | $23.38M | $21.63M | $20.37M | $20.61M | $17.86M | $12.03M | $9.77M | $8.2M | $7.77M | $5.94M | $3.85M | $3.54M | $2.66M | |
| — | — | — | — | — | — | — | $41.92K | — | — | — | — | — | — | — | |
| — | $790.67K | $810.5K | $888.47K | $870.39K | $587.14K | $463.13K | $418.6K | $340.23K | $309.26K | $300.61K | $271.57K | $232.96K | $190.97K | $103.98K | |
| — | $29.38M | $28.58M | $27.78M | $26.98M | $26.15M | $20.8M | $16.19M | $14.27M | $9.65M | $8.31M | $6.42M | — | — | — | |
| — | $9.23M | — | — | — | — | — | — | — | — | — | — | $7.69M | $6.7M | $5.1M | |
| — | -$2.59M | -$2.97M | -$6.45M | -$10.27M | -$10.78M | -$7.03M | -$1.25M | $585.68K | $1.16M | -$736.25K | $1.18M | $1.01M | $1.06M | $1.29M | |
| — | — | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% | -5.19% | 2.53% | 6.71% | -5.99% | 9.65% | 11.58% | 13.68% | 20.17% | |
| — | -$1.8M | -$2.16M | -$5.56M | -$9.4M | -$10.19M | -$6.57M | -$836.19K | $925.91K | $1.47M | -$435.64K | $1.45M | $1.24M | $1.25M | $1.39M | |
| — | — | — | — | — | — | — | — | — | — | $1886 | $3412 | $4547 | $28.28K | $31.54K | |
| — | $335.48K | $356.41K | $382.49K | $496.4K | $105.71K | $665.09K | $60.52K | $110.74K | $28.1K | $2937 | -$9198 | $2782 | -$24.29K | -$7974 | |
| — | -$2.26M | -$2.62M | -$6.06M | -$9.77M | -$10.68M | -$6.36M | $1.19M | $696.42K | $1.18M | -$776.7K | $1.14M | $1.01M | $1.04M | $1.28M | |
| — | — | $21.89K | $2893 | $3.97M | -$2.01M | -$1.8M | -$17.8K | $132.07K | $266.38K | -$241.7K | $359.71K | $307.02K | $312.35K | $465.29K | |
| — | -$2.28M | -$2.64M | -$6.07M | -$13.74M | -$8.66M | -$4.56M | -$1.21M | $564.35K | $910.57K | -$535K | $782.86K | $703.43K | $725.76K | $815.89K | |
| — | — | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% | -5.01% | 2.44% | 5.25% | -4.35% | 6.39% | 8.09% | 9.35% | 12.77% | |
| USD/shares | — | — | -$0.06 | -$0.13 | -$0.30 | -$0.19 | -$0.10 | -$0.03 | $0.01 | $0.02 | -$0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| USD/shares | — | — | -$0.06 | -$0.13 | -$0.30 | -$0.19 | -$0.10 | -$0.03 | $0.01 | $0.02 | -$0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| shares | — | — | 46.19M | 45.8M | 45.6M | 45M | 44.39M | 41.93M | 38.78M | 38.13M | 37.83M | 37.99M | 36.66M | 36.01M | 34.25M |
| shares | — | — | 46.19M | 45.8M | 45.6M | 45M | 44.39M | 41.93M | 39.06M | 38.92M | 37.88M | 37.99M | 36.66M | 36.04M | 35.1M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2019: $27.1K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.30×
EV/EBIT
—
P/E (TTM)
—
Peer median 18.34×
Peer medians compare against the 21 similar-size Medical Instruments & Supplies companies (of 50 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $30,238,333 | $27,506,682 | $23,676,039 | $23,586,254 | $19,488,685 | $20,678,453 |
| Non Us | $10,889,033 | $6,139,781 | $4,841,627 | $4,309,783 | $4,001,490 | $3,497,995 |